BAFF selectively enhances the survival of plasmablasts generated from human memory B cells

被引:411
作者
Avery, DT
Kalled, SL
Ellyard, JI
Ambrose, C
Bixler, SA
Thien, M
Brink, R
Mackay, F
Hodgkin, PD
Tangye, SG
机构
[1] Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia
[2] Biogen Inc, Dept Immunol & Inflammat, Cambridge, MA 02142 USA
[3] Univ Sydney, Sydney, NSW 2006, Australia
[4] St Vincents Hosp, Garvan Inst Med Res, Dept Arthritis & Inflammat, Darlinghurst, NSW 2010, Australia
[5] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
关键词
D O I
10.1172/JCI200318025
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The generation of Ig-secreting cells (ISCs) from memory B cells requires interactions between antigen-specific (Ag-specific) B cells, T cells, and dendritic cells. This process must be strictly regulated to ensure sufficient humoral immunity while avoiding production of pathogenic autoantibodies. BAFF, a member of the TNF family, is a key regulator of B cell homeostasis. BAFF exerts its effect by binding to three receptors - transmembrane activator of and CAML interactor (TACI), B cell maturation antigen (BCMA), and BAFF receptor (BAFF-R). To elucidate the contribution of BAFF to the differentiation of B cells into ISCs, we tracked the fate of human memory B cells stimulated with BAFF or CD40L. BAFF and CD40L significantly increased the overall number of surviving B cells. This was achieved via distinct mechanisms. CD40L induced proliferation of nondifferentiated blasts,. while BAFF prevented apoptosis of ISCs without enhancing proliferation. The altered responsiveness of activated memory B cells to CD40L and BAFF correlated with changes in surface phenotype such that expression of CD40 and BAFF-R were reduced on ISCs while BCMA was induced. These results suggest BAFF may enhance humoral immunity in vivo by promoting survival of ISCs via a BCMA-dependent mechanism. These findings have wide-ranging implications for the treatment of human immunodeficiencies as well as autoimmune diseases.
引用
收藏
页码:286 / 297
页数:12
相关论文
共 61 条
[1]   Generation of plasma cells from peripheral blood memory B cells: Synergistic effect of interleukin-10 and CD27/CD70 interaction [J].
Agematsu, K ;
Nagumo, H ;
Oguchi, Y ;
Nakazawa, T ;
Fukushima, K ;
Yasui, K ;
Ito, S ;
Kobata, T ;
Morimoto, C ;
Komiyama, A .
BLOOD, 1998, 91 (01) :173-180
[2]   Cutting edge:: A/WySnJ transitional B cells overexpress the chromosome 15 proapoptotic Blk gene and succumb to premature apoptosis [J].
Amanna, IJ ;
Clise-Dwyer, K ;
Nashold, FE ;
Hoag, KA ;
Hayes, CE .
JOURNAL OF IMMUNOLOGY, 2001, 167 (11) :6069-6072
[3]   GENERATION OF MEMORY B-CELLS AND PLASMA-CELLS IN-VITRO [J].
ARPIN, C ;
DECHANET, J ;
VANKOOTEN, C ;
MERVILLE, P ;
GROUARD, G ;
BRIERE, F ;
BANCHEREAU, J ;
LIU, YJ .
SCIENCE, 1995, 268 (5211) :720-722
[4]   THE 26-KD TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR-ALPHA ON ACTIVATED CD4+ T-CELL CLONES PROVIDES A COSTIMULATORY SIGNAL FOR HUMAN B-CELL ACTIVATION [J].
AVERSA, G ;
PUNNONEN, J ;
DEVRIES, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1575-1585
[5]   Blood dendritic cells interact with splenic marginal zone B cells to initiate T-Independent immune responses [J].
Balázs, M ;
Martin, F ;
Zhou, T ;
Kearney, JF .
IMMUNITY, 2002, 17 (03) :341-352
[6]   BAFF mediates survival of peripheral immature B lymphocytes [J].
Batten, M ;
Groom, J ;
Cachero, TG ;
Qian, F ;
Schneider, P ;
Tschopp, J ;
Browning, JL ;
Mackay, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1453-1465
[7]   The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS) [J].
Beebe, AM ;
Cua, DJ ;
Malefyt, RD .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) :403-412
[8]   INTERLEUKIN-10 INDUCES B-LYMPHOCYTES FROM IGA-DEFICIENT PATIENTS TO SECRETE IGA [J].
BRIERE, F ;
BRIDON, JM ;
CHEVET, D ;
SOUILLET, G ;
BIENVENU, F ;
GURET, C ;
MARTINEZVALDEZ, H ;
BANCHEREAU, J .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :97-104
[9]   A SUBSET OF CD4(+) MEMORY T-CELLS CONTAINS PREFORMED CD40 LIGAND THAT IS RAPIDLY BUT TRANSIENTLY EXPRESSED ON THEIR SURFACE AFTER ACTIVATION THROUGH THE T-CELL RECEPTOR COMPLEX [J].
CASAMAYORPALLEJA, M ;
KHAN, M ;
MACLENNAN, ICM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1293-1301
[10]   CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells [J].
Cerutti, A ;
Schaffer, A ;
Shah, S ;
Zan, H ;
Liou, HC ;
Goodwin, RG ;
Casali, P .
IMMUNITY, 1998, 9 (02) :247-256